MENU
LVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

LAVA Therapeutics (LVTX) Earnings Date & Reports

LAVA Therapeutics NV isa clinical stage immuno-oncology company... Show more

A.I. Advisor
published Earnings

LVTX is expected to report earnings to rise 155.77% to -33 cents per share on August 26

LAVA Therapeutics LVTX Stock Earnings Reports
Q2'25
Est.
$-0.33
Q1'25
Beat
by $0.19
Q4'24
Beat
by $0.16
Q3'24
Missed
by $0.13
Q2'24
Beat
by $0.02
The last earnings report on May 14 showed earnings per share of -12 cents, beating the estimate of -31 cents. With 14.13K shares outstanding, the current market capitalization sits at 34.20M.
View a ticker or compare two or three
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Yalelaan 62
Phone
+31 850163100
Employees
35
Web
https://www.lavatherapeutics.com